Hostname: page-component-5db58dd55d-bthnr Total loading time: 0 Render date: 2026-06-01T08:49:10.943Z Has data issue: false hasContentIssue false

The experiences and opinions of Polish medical personnel regarding limitations of futile treatment in intensive care units – A questionnaire study

Published online by Cambridge University Press:  29 December 2025

Paweł Melchior Pasieka*
Affiliation:
Centre for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Kraków, Poland
Wojciech Skupnik
Affiliation:
Centre for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Kraków, Poland
Magdalena Fronczek
Affiliation:
Centre for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Kraków, Poland
Roman Jaeschke
Affiliation:
Department of Medicine, McMaster University, Hamilton, ON, Canada Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada
Wojciech Szczeklik
Affiliation:
Centre for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Kraków, Poland
*
Corresponding author: Paweł Melchior Pasieka; Email: pawel.pasieka@doctoral.uj.edu.pl
Rights & Permissions [Opens in a new window]

Abstract

Objectives

Futile treatment is defined as maintenance of organ function without achieving meaningful goals of care. Poland is characterized by low prevalence of introducing limitations of treatment in intensive care units (ICUs). The aim of the study was to conduct a questionnaire study to evaluate the approach of Polish medical personnel to futile treatment in the ICUs.

Materials and Methods

We conducted an anonymous questionnaire study during a national intensive care conference in April 2023. We collected data on participants’ experiences with limiting futile treatment and their demographics. Statistical analysis comparing the responses between respondents with shorter (less than 10 years) or longer (10 years or more) work experience was conducted with a chi-squared test with residual analysis and Bonferroni correction.

Results

354 respondents completed the questionnaire. Most participants (94.5%) found discussing end-of-life care with patients important. Additionally, 81.6% believed that the medical personnel should be more decisive than the patient’s family regarding end-of-life care decisions. While 81% were aware of the existence of futile treatment protocol, only 35% used it regularly. Fear of legal consequences (61.9%) or family’s reaction (55.6%) were the most common reasons for not adhering to existing guidelines. Improving hospital procedures (83.6%) and proper legislation (67.2%) were commonly suggested measures to improve end-of-life care. Respondents with shorter work experience more often reported no awareness of futile treatment protocol (28.7% vs. 6.9%, p < 0.001) as well as no experience discussing treatment limitations with patients (24.6% vs. 8.2%, p < 0.001) or their families (20.0% vs. 3.8%) compared to the clinicians with longer work experience.

Significance of results

Despite widespread recognition of the unethical nature of futile treatment, it remains controversial among Polish ICU clinicians. Improvement of legislation and hospital procedures could contribute to improvement of clinicians’ and patients’ well-being when facing end-of-life care decisions.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press.
Figure 0

Table 1. Demographic data of patients

Figure 1

Table 2. Questions asked in the questionnaire study

Figure 2

Table 3. Responses to Question 1: In your opinion, should we talk to patients about end-of-life care and futile treatment?

Figure 3

Table 4. Responses to Question 2: Assuming that the diagnosis is known, when is the optimal time to discuss goals of care with patients?

Figure 4

Table 5. Responses to Question 3: What should be the balance of decision-making authority regarding treatment limitations between family and medical personnel?

Figure 5

Table 6. Responses to Question 4: Do you find it difficult to discuss futile treatment with the patient, even if you consider it important?

Figure 6

Table 7. Responses to Question 5: Do you find it difficult to discuss futile treatment with the patient’s family, even if you consider it important?

Figure 7

Table 8. Responses to Question 6: Are you familiar with the protocol and guidelines on limiting futile treatment, introduced in 2014 by prof. Kubler’s team and recommended by the Polish Society of Anesthesiology and Intensive Care?

Figure 8

Table 9. Responses to Question 7: What could be the reasons for not adhering to the guidelines and the futile treatment protocol?

Figure 9

Table 10. Responses to Question 8: In your opinion, which initiatives could expand clinicians’ knowledge about futile treatment?

Figure 10

Table 11. Responses to Question 9: Have you talked more often to patients and/or their families about futile therapy since the beginning of the COVID-19 pandemic in Poland (March 2020)?

Figure 11

Table 12. Responses to Question 10: Have you used the futile treatment protocol more frequently since the beginning of the COVID-19 pandemic in Poland (March 2020)?